According to the article the Company which would soon be called RISE Life Science aims to capitalize on California’s burgeoning cannabis industry with a focus on medical grade standardized products, already formulated and ready for market.
“The U.S. cannabis industry is projected to reach $50 billion in size by 2026, according to Cowen & Co., driven by the legalization of medical and adult-use cannabis throughout the country.” States the article.
“California represents the largest market expression of the cannabis industry in the world. And it’s a dynamic environment filled with efforts on all sides to build an access culture that works.” quotes Luminor Technologies CEO.
To read the full article, click here.